tiprankstipranks
Trending News
More News >
Labixiaoxin Snacks Group Ltd. (HK:1262)
:1262
Hong Kong Market
Advertisement

Labixiaoxin Snacks Group Ltd. (1262) AI Stock Analysis

Compare
0 Followers

Top Page

HK:1262

Labixiaoxin Snacks Group Ltd.

(1262)

Rating:51Neutral
Price Target:
HK$2.00
▼(-0.50%Downside)
The primary concern for Labixiaoxin Snacks Group Ltd. is its financial performance, marked by high leverage and operational inefficiencies, resulting in a low score. Technical analysis provides some optimism with potential upward momentum, but valuation concerns persist due to negative profitability and no dividend yield. Overall, the stock's risks outweigh its current technical strengths.

Labixiaoxin Snacks Group Ltd. (1262) vs. iShares MSCI Hong Kong ETF (EWH)

Labixiaoxin Snacks Group Ltd. Business Overview & Revenue Model

Company DescriptionLabixiaoxin Snacks Group Ltd. (1262) is a prominent company in the food and beverage industry, primarily engaged in the production and distribution of various snack products. The company is renowned for its diverse portfolio of snacks, which includes jelly products, confectioneries, and beverages. Labixiaoxin aims to appeal to a broad consumer base through innovative flavors and high-quality ingredients, ensuring a strong presence in both domestic and international markets.
How the Company Makes MoneyLabixiaoxin Snacks Group Ltd. generates revenue primarily through the production and sale of its snack products. The company operates a vertically integrated business model, where it controls the manufacturing, distribution, and marketing of its product lines. Key revenue streams include sales from its core snack categories such as jelly products, candies, and beverages. Additionally, Labixiaoxin leverages strategic partnerships with retailers and distributors to expand its market reach, both in China and abroad. The company's ability to innovate with new product offerings and flavors, along with its strong brand recognition, also plays a critical role in driving sales and maintaining a competitive edge.

Labixiaoxin Snacks Group Ltd. Financial Statement Overview

Summary
Labixiaoxin Snacks Group Ltd. exhibits revenue growth but faces challenges in profitability and cash flow generation. High leverage and declining equity are key risks, while operational inefficiencies further pressure financial stability. Strategic improvements are necessary to enhance financial health.
Income Statement
45
Neutral
The company shows some revenue growth with a 13.39% increase from 2023 to 2024, but profitability is a concern given the negative net profit margin of -10.79% for 2024. The gross profit margin is 27.06%, indicating some cost control, but negative EBIT and EBITDA margins suggest operational inefficiencies.
Balance Sheet
40
Negative
The high debt-to-equity ratio of 2.13 in 2024 indicates significant leverage, posing financial stability risks. The equity ratio is 27.02%, showing moderate asset financing by equity, but a declining trend in stockholders' equity suggests weakened financial health.
Cash Flow
30
Negative
The absence of positive operating cash flow and free cash flow in 2024 is concerning, highlighting potential liquidity issues. Previous periods showed improvement in free cash flow, but the lack of data for 2024 prevents a comprehensive analysis.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue866.67M764.38M684.26M648.07M508.84M
Gross Profit234.62M218.94M244.19M224.28M166.54M
EBITDA-35.72M-46.04M658.00K81.80M108.73M
Net Income-93.46M-104.75M-75.33M-65.20M-29.40M
Balance Sheet
Total Assets793.84M810.91M977.31M1.29B1.53B
Cash, Cash Equivalents and Short-Term Investments52.50M44.32M71.88M80.57M258.84M
Total Debt456.40M451.27M512.44M565.59M690.74M
Total Liabilities579.32M588.35M650.00M887.41M1.06B
Stockholders Equity214.52M222.56M327.31M402.64M467.84M
Cash Flow
Free Cash Flow-34.23M55.42M-4.98M-156.86M-21.57M
Operating Cash Flow31.53M88.64M15.46M-135.29M-12.47M
Investing Cash Flow-65.54M-32.89M55.94M113.42M300.93M
Financing Cash Flow42.19M-83.31M-80.09M-156.41M-54.46M

Labixiaoxin Snacks Group Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2.01
Price Trends
50DMA
2.00
Positive
100DMA
1.70
Positive
200DMA
1.71
Positive
Market Momentum
MACD
-0.03
Positive
RSI
46.43
Neutral
STOCH
36.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1262, the sentiment is Positive. The current price of 2.01 is below the 20-day moving average (MA) of 2.07, above the 50-day MA of 2.00, and above the 200-day MA of 1.71, indicating a neutral trend. The MACD of -0.03 indicates Positive momentum. The RSI at 46.43 is Neutral, neither overbought nor oversold. The STOCH value of 36.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1262.

Labixiaoxin Snacks Group Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
HK$1.73B8.4112.91%7.03%9.63%20.08%
77
Outperform
HK$1.02B8.155.39%16.34%-1.88%129.25%
68
Neutral
HK$423.30M7.175.59%10.65%4.97%-16.24%
66
Neutral
HK$1.04B45.541.74%1.57%-0.82%
65
Neutral
HK$295.00M7.998.18%2.40%>-0.01%16.04%
61
Neutral
HK$21.17B12.340.81%4.52%2.72%-47.45%
51
Neutral
HK$439.02M-42.82%10.98%29.31%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1262
Labixiaoxin Snacks Group Ltd.
2.01
0.68
51.13%
HK:2317
Vedan International (Holdings) Ltd.
0.67
0.14
26.42%
HK:1837
Natural Food International Holding Ltd.
0.79
0.34
75.56%
HK:1767
TS Wonders Holding Limited
0.30
0.10
50.00%
HK:1285
Jiashili Group Ltd
1.01
0.03
3.06%
HK:1583
Qinqin Foodstuffs Group (Cayman) Company
1.38
0.53
63.31%

Labixiaoxin Snacks Group Ltd. Corporate Events

Labixiaoxin Snacks Group Ltd. Unanimously Passes AGM Resolutions
Jun 19, 2025

Labixiaoxin Snacks Group Ltd. announced that all ordinary resolutions proposed at their Annual General Meeting on June 19, 2025, were passed unanimously. This includes the adoption of financial statements, re-election of directors, and granting a mandate to issue shares, reflecting strong shareholder support and potentially impacting the company’s strategic operations and market positioning positively.

Labixiaoxin Snacks Group Ltd. Updates Nomination Committee Structure
Jun 19, 2025

Labixiaoxin Snacks Group Ltd. has revised the terms of reference for its Nomination Committee, emphasizing a structure that includes a majority of independent non-executive directors and gender diversity among its members. This move is aimed at enhancing governance and ensuring diverse perspectives in decision-making, potentially impacting the company’s strategic direction and stakeholder confidence.

Labixiaoxin Snacks Group Ltd. Updates Nomination Committee Composition
Jun 19, 2025

Labixiaoxin Snacks Group Ltd. announced a change in the composition of its Nomination Committee, with Ms. Wu Qiongyao replacing Mr. Zheng Yu Shuang as a member, effective June 19, 2025. This change aligns with amendments to the Listing Rules and Corporate Governance Code, aiming to enhance the board’s effectiveness and diversity, thereby improving the company’s corporate governance practices.

Labixiaoxin Snacks Group Ltd. Announces Board Composition and Roles
Jun 19, 2025

Labixiaoxin Snacks Group Ltd. has announced the composition of its board of directors, highlighting the roles and functions of each member. The board includes executive, non-executive, and independent non-executive directors, with specific members assigned to the audit, nomination, and remuneration committees. This announcement provides clarity on the governance structure, potentially impacting the company’s strategic direction and stakeholder confidence.

Labixiaoxin Snacks Group Ltd. Announces 2025 Annual General Meeting
Apr 28, 2025

Labixiaoxin Snacks Group Ltd. has announced its upcoming annual general meeting scheduled for June 19, 2025, in Hong Kong. Key agenda items include the adoption of financial statements for 2024, re-election of directors, and authorization for the board to fix remuneration for directors and auditors. The meeting will also consider resolutions to empower directors to manage share-related activities, which could impact the company’s capital structure and shareholder value.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 18, 2025